
Photo from
May 29, 2024, 23:25
Shilpa Gupta: Honored and humbled to present the PROs from EV-302 of EV-P vs plat in mUC ASCO
Shilpa Gupta shared a post on X:
“Honored and humbled to present the PROs from EV-302 of EV-P vs plat in mUC ASCO Mon, Jun 3, 8 AM session co-chaired by Maite Bourlon, Suzanne Cole.”
Source: Shilpa Gupta/X
Dr. Shilpa Gupta is the Director of Genitourinary Medical Oncology at Taussig Cancer Institute and Co-Leader of the Genitourinary Oncology Program at Cleveland Clinic. Dr. Gupta’s extensive research focuses on novel drug development and biomarkers of response/resistance in bladder cancer, contributing to numerous published works and leadership roles in clinical trials.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Feb 21, 2025, 15:06
Feb 21, 2025, 14:27
Feb 21, 2025, 14:13
Feb 21, 2025, 13:29